Diabetes Association of Bangladesh (BADAS) has signed a Memorandum of Understanding (MoU) with Experto Limited, the representative of Twin Health today (Sunday, 28 April, 2024) at the Pan Pacific Sonargaon Hotel to introduce the cutting-edge Twin Precision Treatment (TPT) technology at BADAS facilities. The primary objective of this collaboration is to address remission of prevalent metabolic disorders such as Type 2 Diabetes, and Pre-diabetes. National Professor AK Azad Khan, President, BADAS and Md. Moinul Hakim, Managing Director, Experto Limited along with the Senior officials of both the organization present at the occasion. 

In the past, diabetes was often viewed as a lifelong condition; however, pioneering research by Professor Dr. Ros Taylor challenged this notion, demonstrating that diabetes can be reversible, and even remission is possible. An international group of diabetes experts worked together to standardize and simplify the criteria for diabetes remission, agreeing that an individual with type 2 diabetes is in remission if they maintain an HbA1c level below 6.5% (48 mmol/mol) for at least three months and if they have not taken any medications to manage their blood glucose levels during this time.

The TPT technology, developed by Twin Health and utilizing AI-enabled platforms, has shown promising results, achieving the highest reported rate of type 2 diabetes remissions to date. These findings were presented during a late-breaking poster session at the 82nd Scientific Sessions of the American Diabetes Association® (ADA) held in New Orleans, LA, on June 4, 2022.

The innovative AI-enabled TPT platform collects lab reports and daily inputs from various monitoring devices, such as glucose monitors, sensor watches, blood pressure meters, and smart scales, along with detailed patient food intake information. Through the integration of AI and IoT, the platform provides personalized health insights and recommends highly-tailored treatments based on the unique metabolic profile of each patient.

The TPT technology focuses on healing the damaged metabolism through a four-quarter process, which includes normalization of blood sugar, optimization of chronic conditions like cholesterol and hypertension, organ (liver, kidney and pancreas) optimization, and Beta cells reactivation along with improving insulin resistance. The technology offers individualized guidance and real-time accountability through an easy-to-use app monitored by a dedicated care team comprising health coaches and doctors.